The Procter & Gamble Company PG
Household & Personal Products, Consumer Defensive
$147.82
−0.40%
- Market cap
- $343.6B
- PE
- 22.3×
- 10y median 25.2×
- Forward PE
- Price to sales
- 3.9×
- EV/EBIT
- 18.6×
- Revenue, 12 months
- $87B
- +3% on a year ago
- Net margin
- 18.4%
- Free cash flow yield
- 4.4%
Procter & Gamble trades at 22.3× trailing earnings, cheaper than 75% of the last ten years. Revenue was $87B over the last twelve months, up 3% on a year earlier with a 18% net margin.
Charts
Financials
| Income statement | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $21.4B | $20.2B | $20.5B | $21.7B | $21.9B+2% | $19.8B−2% | $20.9B+2% | $22.4B+3% | $22.2B+2% | $21.2B+7% | $21.2B+2% | |
| Cost of revenue | $10.1B | $9.9B | $10.3B | $10.4B | $10.4B+3% | $9.7B−2% | $10.6B+3% | $10.9B+5% | $10.8B+4% | $10.7B+11% | $10.9B+3% |
| Gross profit | $11.3B | $10.3B | $10.2B | $11.3B | $11.5B+2% | $10.1B−3% | $10.3B+1% | $11.5B+2% | $11.4B−1% | $10.5B+4% | $10.3B+0% |
| SG&A | $5.5B | $5.9B | $6.3B | $5.5B | $5.7B+4% | $5.5B−6% | $5.9B−6% | $5.6B+2% | $6B+5% | $5.9B+8% | $6.3B+7% |
| $4.4B | $4.5B | $3.9B | $5.8B | $5.7B+30% | $4.6B+2% | $4.4B+12% | $5.9B+1% | $5.4B−7% | $4.6B+0% | $4B−9% | |
| Interest expense | $248M | $233M | $220M | $238M | $240M−3% | $217M−7% | $212M−4% | $197M−17% | −$220M | $223M+3% | $677M+219% |
| Pre-tax income | $4.5B | $4.6B | $3.9B | $5.1B | $5.8B+30% | $4.7B+2% | $4.5B+17% | $6B+17% | $5.4B−7% | $5B+7% | $3.9B−13% |
| $1B | $812M | $726M | $1.2B | $1.2B+18% | $868M+7% | $895M+23% | $1.3B+9% | $1.1B−8% | $1B+20% | $852M−5% | |
| Net income | $3.5B | $3.8B | $3.1B | $4B | $4.6B+34% | $3.8B+0% | $3.6B+15% | $4.8B+20% | $4.3B−7% | $3.9B+4% | $3B−16% |
| $1.40 | $1.52 | $1.27 | $1.61 | $1.88+34% | $1.54+1% | $1.48+17% | $1.95+21% | $1.78−5% | $1.63+6% | $1.26−15% | |
| 2.5B | 2.5B | 2.5B | 2.5B | 2.5B−0% | 2.4B−1% | 2.5B−1% | 2.4B−1% | 2.4B−1% | 2.4B−1% | 2.4B−1% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Consumer Defensive within ten times Procter & Gamble's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| PGThe Procter & Gamble Company | $343.6B | 22.3× | 25.2× | 3.9× | +3% | 18.4% | |
| KOThe Coca-Cola Company | $369.2B | 25.8× | 27.7× | 7.4× | +7% | 28.6% | |
| PMPhilip Morris International Inc. | $300.3B | 27.7× | 18.4× | 7.1× | +9% | 25.6% | |
| COSTCostco Wholesale Corporation | $417.5B | 45.4× | 38.4× | 1.4× | +10% | 3.0% | |
| PEPPepsiCo, Inc. | $168.9B | 16.2× | 25.8× | 1.7× | +6% | 10.8% | |
| WMTWalmart Inc. | $858.1B | 39.0× | 31.2× | 1.2× | +6% | 3.0% | |
| MOAltria Group, Inc. | $115.8B | 14.6× | 13.2× | 4.9× | −1% | 34.0% | |
| MNSTMonster Beverage Corporation | $84B | 39.5× | 37.7× | 9.1× | +20% | 23.1% | |
| MDLZMondelez International, Inc. | $75.8B | 21.8× | 22.5× | 1.9× | +7% | 8.9% | |
| CLColgate-Palmolive Company | $69.5B | 34.6× | 27.2× | 3.3× | +5% | 9.7% | |
| TGTTarget Corporation | $68.6B | 15.7× | 15.7× | 0.6× | +2% | 4.1% | |
| Peer median | $142.4B | 26.7× | 26.5× | 2.6× | +6% | 10.2% |
About
- Chief executive
- Shailesh Jejurikar, since 2026Joined 1989, CEO since January 2026. Source
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
Valuation data, not investment advice. Prices as of .